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Science Center, Beijing, China
The female vaginal environment contains diverse microorganisms, and their interactions
play significant roles in health and disease. Lactobacillus species are the predominant
vaginal microorganisms in healthy women and relevant as a barrier to defense against
pathogens, including Candida albicans. The yeast-to-hyphae transition is believed to be
a determinant of C. albicans pathogenesis. In this study, we investigated the effects of
vaginal isolates of L. crispatus (seven strains), L. gasseri (six strains), and L. jensenii
(five strains) on growth, hyphal formation and virulence-related genes expression of
C. albicans ATCC 10231. We found that the L. crispatus showed the most significant
antimicrobial activities in microplate-based liquid medium assay (P < 0.05). All seven
cell-free supernatants (CFS) from L. crispatus strains reduced the growth of C. albicans
by >60%. The effects might be due to their productions of some secretory antimicrobial
compounds in addition to H2O2 and organic acids. Furthermore, each of the CFS of
Lactobacillus strains was found to significantly suppress the yeast-to-hyphae transition
of C. albicans under hyphae-inducing conditions (RPMI 1640 medium supplemented
with 10% fetal bovine serum). The hyphae inhibition rates of C. albicans treated by CFS
from L. crispatus, L. gasseri, and L. jensenii were 88.3 ± 3.02%, 84.9 ± 6.0%, and
81.9 ± 6.2%, respectively. Moreover, the expression of hyphae-specific genes (ALS3,
HWP1, ECE1, EAP1, and SAP5) and transcriptional regulatory genes (EFG1, TEC1,
and NRG1) were analyzed using quantitative real-time PCR. The results demonstrated
that L. crispatus CFS significantly down-regulated the expression of hyphae-specific
genes ALS3 (0.140-fold)), HWP1 (0.075-fold), and ECE1 (0.045-fold), while up-regulated
the expression of the negative transcriptional regulator gene NRG1 with 1.911-fold.
The antimicrobial compounds from L. crispatus B145 against Candida growth were
heat stable and protease resistance, but those against hyphal formation were partially
sensitive to the same treatments. Our novel findings suggest that L. crispatus, a
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dominant Lactobacillus species associated with a healthy vagina, could strongly inhibit
C. albicans growth and hyphal formation. L. crispatus might repress the expression
of hyphae-specific genes (ALS3, HWP1, and ECE1) in a NRG1-dependent manner.
Besides, L. crispatus B145 is highly worthwhile for probiotic investigation.
Keywords: Lactobacillus, Candida albicans, microbiota, vulvovaginal candidiasis, antimicrobial activity, yeast-to-
hyphae
INTRODUCTION
Candida albicans is an opportunistic pathogen and the most
prevalent fungal species of the human microbiota (da Silva
Dantas et al., 2016). In individuals with healthy immune systems,
C. albicans asymptomatically colonizes mucosal surfaces.
However, in some conditions this species can cause infections,
such as VVC (Nobile and Johnson, 2015). The overgrowth and
morphological transition (e.g., yeast-to-hyphae transition) of
C. albicans are very important determinants to promote the
conversion from a commensal to a pathogen (Jacobsen et al.,
2012). VVC is responsible for a great morbidity among women
of reproductive-age and significant burden to the health care
system due to rising vaginitis-related health care costs. It is
estimated that about 75% of all women at the childbearing age
are aﬄicted by VVC at least once in their lifetime with∼40–50%
experiencing at least one additional episode of infection, ∼5–8%
of women suffer from at least four recurrent VVC per year
(Peters et al., 2014; Cassone, 2015).
It is well accepted that the interactions between C. albicans
and other components of the resident bacteria, particularly
Lactobacillus spp., play important roles in determining the
commensal or pathogenic outcome of this fungus (Förster
et al., 2016). Lactobacilli are predominant microorganisms in the
normal vaginal microbiota, where the most frequently isolated
species are L. crispatus, L. gasseri, and L. jensenii (Petrova et al.,
2015). In a healthy status, C. albicans and lactobacilli naturally
co-inhabit in the female genitourinary tract, where the former
lives as a minority co-habitant. It is reported that lactobacilli
could inhibit the overgrowth of C. albicans by producing a
wide variety of secondary metabolites with antimicrobial activity,
such as lactic acid, hydrogen peroxide (H2O2), bacteriocin-like
compounds, and biosurfactants (Borges et al., 2014). For instance,
bacteriocin L23 produced by L. fermentum isolate displayed
inhibition effect on C. albicans growth (Pascual et al., 2008).
However, the mechanisms underlying anti-Candida activity are
still not clearly understood.
When the balance of vaginal flora is disturbed by the weakened
immune system, antibiotic usage and other risk factors, the
Abbreviations: ALS3, agglutinin-like protein 3; CD, colony diameter; CFS, cell-
free supernatant; EAP1, extracellular adherence protein 1; ECE1, extent of cell
elongation protein 1; EFG1, enhanced filamentous growth 1; FBS, fetal bovine
serum; GIA, growth inhibitory activity; GSP1, GTP binding protein 1; HWP1,
hyphal wall protein 1; IZD, inhibition zone diameter; MRS, Man, Rogosa, and
Sharpe; NRG1, negative regulator of glucose-repressed 1; OD, optical density; PBS,
phosphate buffered saline; qRT-PCR, quantitative real-time reverse transcription
PCR; SAP5, secreted aspartyl proteinase 5; SD, standard deviation; TEC1,
transposon enhancement control 1; VVC, vulvovaginal candidiasis; YPD, yeast
extract-peptone-dextrose.
lactobacilli biomass would decrease and its species composition
might shift, while C. albicans could overgrow and undergo a
morphogenetic change from a round-ovoid typical yeast cell to
a hyphal growing organism (Ma et al., 2012; Cassone, 2015).
The yeast-to-hyphae transition is believed to be a determinant
of C. albicans pathogenesis, and it could be triggered by various
environmental cues in vitro, including neutral pH, presence
of serum or N-acetyl glucosamine, elevated carbon dioxide
concentration and physiological temperature (Mayer et al., 2013;
Palková and Váchová, 2016). In addition, the morphological
transition from yeast to hyphae is regulated by a complex
network of signaling pathway in C. albicans. Several virulence-
related genes that are specifically expressed in hyphae have been
suggested to play essential roles in C. albicans pathogenesis
(Sudbery, 2011; Jacobsen et al., 2012). For example, the hyphal
wall protein 1 gene (HWP1), agglutinin-like protein gene 3
(ALS3), and extent of cell elongation gene 1 (ECE1) encode
cell surface proteins, which are important for hyphal growth
and adhesion to host cells (Fan et al., 2013; Vila et al.,
2016). Expressions of these hyphae-specific genes are positively
regulated by transcription factors Efg1 and Tec1, and are
also negatively regulated by the transcriptional repressors Nrg1
(Shapiro et al., 2011).
The use of probiotic lactobacilli against VVC has emerged as
an attractive therapeutic option in the era of antibiotic resistance
(Matsubara et al., 2016a). Several clinical trials reported that
the commercially available probiotic Lactobacillus spp., such
as L. rhamnosus GR-1, L. reuteri RC-15, and L. plantarum
I1001, are beneficial to women’s urogenital health by decreasing
the risk of VVC (Reid et al., 2003; Martinez et al., 2009;
Murina et al., 2014; Palacios et al., 2016). However, they are
seldom reported as the main resident Lactobacillus species
in healthy vagina. Moreover, little is known about the roles
and underlying mechanisms of yeast-to-hyphae transition in
C. albicans regulated by lactobacilli, especially by those resident
Lactobacillus species (Orsi et al., 2014b; Matsubara et al., 2016b;
Oliveira et al., 2016).
The aim of this study was to investigate the effects of
the most frequently found Lactobacillus spp. in the healthy
vagina, i.e., L. crispatus, L. gasseri, and L. jensenii, on growth,
hyphal formation and virulence-related genes expression of
C. albicans. We found that all 18 Lactobacillus strains tested
could inhibit the growth and hyphal formation of C. albicans
in a strain-specific manner. In addition, for the first time,
we demonstrated that L. crispatus inhibited C. albicans hyphal
formation by down-regulating the hyphae-specific genes ALS3,
HWP1, and ECE1 possibly through up-regulating the expression
of transcriptional repressor gene NRG1. Having the strongest
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inhibition effects on C. albicans growth and hyphal formation,
and being the most commonly found resident Lactobacillus
species in the healthy vagina, L. crispatus shows a great potential
as a probiotic candidate.
MATERIALS AND METHODS
Strains and Culture Conditions
Eighteen Lactobacillus strains of three different species
(L. crispatus, L. gasseri, and L. jensenii) were originally
isolated from human vaginal secretion (Wang et al., 2014,
2015). L. acidophilus ATCC 4356 and C. albicans ATCC 10231
were purchased from the China General Microbiological Culture
Collection Center.
All Lactobacillus strains were routinely grown in MRS
medium (BD, Sparks, MD, USA) and incubated in an anaerobic
atmosphere (BD, Sparks, MD, USA) at 37◦C for 48 h. C. albicans
was routinely grown for 12 h at 37◦C in YPD medium.
Determination of H2O2 Production
The qualitative plate assay for H2O2 production was carried
out according to the method of Xu et al. (2008). In brief,
following 48 h of anaerobic incubation on the TMB-HRP-
MRS plates [MRS agar containing 250 µg/mL 3, 3′, 5, 5′-
tetramethylbenzidine (TMB; Amresco, Solon, OH, USA) and
50µg/mL horseradish peroxidase (HRP; Biodee, Beijing, China)],
the colonies of H2O2-producing strains turned blue after 30 min
air exposure. Based on the color intensity, the potential of H2O2
production could be divided into four categories: negative (-
), weakly positive (+), positive (++), and strongly positive
(+++) (Xu et al., 2008). L. acidophilus ATCC 4356 was
used as a positive control, and graded as a strong H2O2
producer.
Preparation of Cell-Free Supernatant
(CFS) from Lactobacillus Strains and pH
Measurement
Lactobacilli were grown in MRS broth (pH 6.5) for 48 h at
37◦C in anaerobic condition. CFS was prepared by centrifuging
the culture at 8000 rpm for 15 min at 4◦C and then filtered
through 0.22 µm filters (Millipore, Bedford, MA, USA). The
pH value of CFS was measured by using a pH meter (PHS-3E,
INESA Scientific Instrument, Shanghai, China). CFS was stored
as single-use aliquots at -20◦C until needed.
Antimicrobial Activity of Lactobacilli
against C. albicans
The modified agar overlay method was used to determine
the antimicrobial activity of lactobacilli against C. albicans
(do Carmo et al., 2016). Ten microliter of Lactobacillus spp.
suspensions (∼106 CFU/mL) were spotted onto MRS agar plates,
and incubated anaerobically for 48 h. The MRS agar plates
containing the growth of lactobacilli (≈8 mm in diameter) were
overlayed with a C. albicans suspension (∼107 CFU/mL) in
10 mL of YPD soft agar (0.5% agar). The inhibitory effect of
MRS was tested as a negative control on each plate. After aerobic
incubation for 24 h, inhibition zones were read. The GIA was
calculated as follows: GIA (mm) = (IZD – CD)/2, where IZD
was inhibition zone diameter and CD was colony diameter of a
Lactobacillus spot. A GIA grading system was applied, in which
GIA < 0.5 mm was recorded as negative (–), (0.5, 2) mm as
weak positive (+), (2, 3.5) mm as intermediate positive (++),
and ≥ 3.5 mm as strong positive (+++).
Antimicrobial Activity of CFS against
C. albicans
A microplate assay was used to evaluate the antimicrobial activity
of the CFS against C. albicans according to Parolin et al. (2015)
with some modifications. A mixture of 100 µL C. albicans
suspensions in YPD broth (∼106 CFU/mL) and 100 µL tested
CFS was added to each well of a sterile 96-well microplate (Costar
3799, Corning, NY, USA). MRS broth was used instead of CFS
as a positive growth control. The plate was incubated at 37◦C
aerobically for 24 h, and the growth of C. albicans was recorded as
OD at 630 nm wavelength using a microplate reader (Model 680,
Bio-Rad, Hercules, CA, USA). The growth inhibition rate (%) was
expressed as: (ODcontrol – ODCFS)/ODcontrol × 100.
Effect of CFS on C. albicans Hyphal
Formation
Hyphal growth assay of C. albicans was performed in RPMI 1640
medium supplemented with 10% FBS (Sun et al., 2015). We used
both solid and liquid medium assays to evaluate the effects of CFS
on C. albicans hyphal formation. In these two assays, MRS broth
instead of CFS was used as control. All assays were repeated for
five times.
For solid medium assay, C. albicans cells from an overnight
culture were washed with PBS and spread (∼100 colonies per
plate) on plates of solidified medium supplemented with 50µL of
CFS. Plates were aerobically incubated at 37◦C for 5 days. Images
of colony edges were obtained using a stereomicroscope (SZ66,
Optec, Chongqing, China).
To assess the effect of CFS in liquid medium, a mixture of
900 µL C. albicans suspensions (∼106 CFU/mL) in medium
and 100 µL CFS was added into each well of a 48-
well microplate, and aerobically incubated at 37◦C for 4 h.
Quantification of inhibition of the yeast-to-hyphae transition
was accomplished by counting the number of individual
yeast cells versus the number of hyphae in the population
under a light microscope (AxioCam MRc5; Carl Zeiss, Jena,
Germany). More than 100 cells were counted for each well
in duplicate, and all assays were repeated for five times. The
hyphae inhibition rate (%) was calculated as: (Hyphae%control –
Hyphae%CFS)/Hyphae%control × 100.
Quantitative Real-Time Reverse
Transcription PCR (qRT-PCR)
To determine the effects of CFS in RPMI 1640 + 10% FBS
broth on the transcription of C. albicans genes related to
yeast-to-hyphae transition, gene expression levels of GSP1,
NRG1, TEC1, EFG1, EAP1, SAP5, ALS3, HWP1, and ECE1
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were evaluated by two-step qRT-PCR (Sun et al., 2015; James
et al., 2016). Total RNA of C. albicans was extracted using
a Yeast RiboPure RNA Purification kit (CoWin Biosciences,
Beijing, China). Concentration, purity, and quality of the
isolated RNA samples were determined using a Nano Drop
One Spectrophotometer (Thermo Scientific, Waltham, MA,
USA). RNA (1 µg) from each sample was immediately reverse
transcribed into cDNA using a Prime Script RT reagent
kit (Takara, Tokyo, Japan) according to the manufacturer’s
instructions. The conditions for reverse transcription were
15 min at 37◦C, 5 s at 85◦C. qRT-PCR was performed with
80 ng cDNA template and SYBR Premix Ex Taq (Takara) in ABI
StepOne Real Time PCR System (Applied Biosystems). Primer
sequences used for amplification of specific genes were shown
in Table 1. GSP1, which was not transcriptionally regulated
in the morphogenesis switch, served as the internal control
(Sun et al., 2015). The following parameters were used for
qRT-PCR: one cycle at 95◦C for 15 s, 40 cycles at 95◦C for
5 s and then 60◦C for 30 s. Specificity of the primers was
confirmed by melting curve analysis. The generated CT values
of target genes were normalized to the CT value of reference
gene GSP1. Relative expression fold changes were evaluated by
11CT method using 2−11CT formula (Livak and Schmittgen,
2001).
Statistical Analysis
All assays were carried out in triplicate on at least three
different occasions with independently grown cultures unless
otherwise stated. All statistical analysis was performed using
IBM SPSS Statistics 20.0 software program (IBM, Armonk,
NY, USA). Statistical comparison between two groups was
performed by Student’s t-test. Comparisons among multiple
groups were performed by one-way ANOVA followed by
TABLE 1 | List of primers used for qRT-PCR experiments.
Gene Function Primer sequence (5′–3′)
GSP1 GTP-binding protein
(Reference gene)
F: TGAAGTCCATCCATTAGGAT
R: ATCTCTATGCCAGTTTGGAA
NRG1 Negative transcriptional
regulator
F: CACCTCACTTGCAACCCC
R: GCCCTGGAGATGGTCTGA
TEC1 Conserved
filamentation activator
F: AGGTTCCCTGGTTTAAGTG
R: ACTGGTATGTGTGGGTGAT
EFG1 Filamentous growth
protein
F: TATGCCCCAGCAAACAACTG
R: TTGTTGTCCTGCTGTCTGTC
EAP1 Extracellular adherence
protein
F: CTGCTCACTCAACTTCAATTGTCG
R: GAACACATCCACCTTCGGGA
SAP5 Secreted aspartyl
proteinase
F: CAGAATTTCCCGTCGATGAGA
R: CATTGTGCAAAGTAACTGCAACAG
ALS3 Agglutinin-like protein F: CTAATGCTGCTACGTATAATT
R: CCTGAAATTGACATGTAGCA
HWP1 Hyphal cell wall protein F: TGGTGCTATTACTATTCCGG
R: CAATAATAGCAGCACCGAAG
ECE1 Extent of cell elongation
protein
F: GCTGGTATCATTGCTGATAT
R: TTCGATGGATTGTTGAACAC
LSD test. A P-value < 0.05 was considered statistically
significant.
RESULTS
Antimicrobial Activity and H2O2
Producing Ability of Lactobacilli
The antimicrobial activity of lactobacilli against C. albicans was
evaluated using agar overlay method. The results showed that 15
of 18 (83.3%) Lactobacillus strains isolated from vaginal mucosa
had inhibition activities on C. albicans growth (Table 2), among
which more than half (8/15, 53.3%) had high inhibition activities
ranked as+++.
The production of H2O2 by Lactobacillus strains was tested
using the semi-qualitative TMB-HRP-MRS assay (Table 2). The
strong-, moderate-, weak- and non-producers were 50.0% (9/18),
22.2% (4/18), 5.6% (1/18), and 22.2% (4/18), respectively.
Effect of CFS on C. albicans Growth
The strains of lactobacilli were assayed for their ability to
produce inhibition compounds in CFS against the growth of
C. albicans. The average pH value of CFS was 4.0 (in the range
of 3.8–4.2), which was lower than fresh MRS broth (initial
pH 6.5) (Table 2). To investigate whether low pH contributed
TABLE 2 | Characteristics of 18 vaginal Lactobacillus strains.
Strain pH of CFS H2O2 producing abilitya GIAb
L. crispatus
A014 3.91 ++ +++
A055 3.95 ++ ++
B125 3.93 +++ ++
B135 3.94 +++ +++
B145 3.93 +++ +++
B422 3.93 ++ +++
B535 3.93 +++ ++
L. gasseri
A054 3.92 − ++
B062 3.86 + +
B351 3.93 +++ +++
B451 3.95 − ++
B542 3.97 − ++
B554 3.93 − +++
L. jensenii
A083 4.09 +++ −
B021 4.09 +++ −
B101 4.02 +++ +++
B161 3.96 ++ −
B511 4.16 +++ +++
aThe H2O2 producing ability of Lactobacillus strains was graded as strongly
positive (+++), positive (++), weakly positive (+), and negative (-) according the
color intensity of colony on the TMB-MRS plate. bThe GIA was calculated by
subtracting a CD of a Lactobacillus spot from the IZD and expressed as follows:
GIA = (IZD – CD)/2. GIA < 0.5 mm was recorded as negative (-), [0.5, 2) mm as
weak positive (+), [2, 3.5) mm as intermediate positive (++), and ≥ 3.5 mm as
strong positive (+++).
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to the growth inhibition effects of CFS, fresh MRS broth was
adjusted to pH 4.0 with HCl (MRS-HCl). In the presence of
CFS or MRS-HCl, the growth of C. albicans was significantly
reduced when compared to the MRS control in general (Figure 1)
(P < 0.01). In addition, while the MRS-HCl could significantly
inhibit the growth of C. albicans (OD630 nm MRS-HCl vs. control:
0.861± 0.122 vs. 1.021± 0.103, P= 0.008), each of the CFS could
further inhibit C. albicans growth with significant difference
compared to MRS-HCl (P < 0.01).
In order to test whether the antimicrobial activity was due
to H2O2, the CFS was treated with catalase enzyme (1 mg/mL;
Sigma, St. Louis, MO, USA) at 37◦C for 1 h before approaching
to the inhibition assay (Figure 2). The antimicrobial activity of
six CFS (B125, B145, B422, B535, B021, and B101) was resistance
to the catalase treatment (P > 0.05). These results suggested
that these six strains might produce anti-Candida compounds
with strong activities beyond the effect of H2O2. After catalase
treatment, the growth inhibition rates of three CFS (A014,
A055, and A083) were found to decrease, indicating that the
observed anti-Candida effects of these three strains were partially
attributed to the production of H2O2 (P < 0.05). However, it
was strange that the growth inhibition abilities of five CFS (B135,
B062, B351, B161, and B511) were found to significantly increase
after catalase treatment.
Effect of CFS on C. albicans Hyphal
Formation
The effect of CFS on the hyphal formation was evaluated in
RPMI 1640 agar medium containing 10% FBS (hypha-inducing
condition). The yeast form and filamentous-proned colonies of
C. albicans were counted. The results showed that the treatment
with CFS was able to inhibit filamentation. Figure 3A was an
example of C. albicans colony at absence or presence of CFS. In
addition, the effect of CFS on the hyphal formation was evaluated
in liquid medium supplemented with CFS. The results showed
that most C. albicans cells grew as yeast (Figure 3B). As seen
in Figure 4, about 98% of untreated cells formed hyphae and
pseudohyphae over 4 h time course. When treated by MRS-HCl,
there was a significant lower ratio of hyphal cells compared to that
treated by MRS control (92.6± 8.0% vs. 97.8± 4.6%, P= 0.038).
However, each of the CFS showed more significant inhibition
effects on C. albicans hyphal formation compared to that of
MRS-HCl (P < 0.01).
Comparison of Inhibitory Activities of
Lactobacillus Species
As shown in Figure 5, the growth and hyphal formation of
C. albicans were inhibited by CFS from L. crispatus, L. gasseri,
and L. jensenii. The growth inhibition rate of C. albicans treated
by L. crispatus (71.1 ± 5.2%) was significantly higher than those
treated by L. gasseri (57.1 ± 6.3 %) or L. jensenii (57.4 ± 9.9%),
respectively (P < 0.01). The hyphae inhibition rate of C. albicans
treated by L. crispatus (88.3 ± 3.02%) was significantly higher
than that by L. jensenii (81.9 ± 6.2%) (P < 0.05). However, there
was no significant difference between L. crispatus and L. gasseri
treatments (88.3 ± 3.0% vs. 84.9 ± 6.0%, P > 0.05). Taking
into consideration of growth and hyphal formation inhibition
activities, we chose L. crispatus CFS to study the effects on the
transcription of C. albicans virulence-related genes.
Modulation of C. albicans Gene
Expression by CFS
The expression levels of the hyphae-specific genes (ALS3,
HWP1, ECE1, EAP1, and SAP5) and transcriptional regulatory
genes (EFG1, TEC1, and NRG1) were quantified in C. albicans
incubated with CFS by qRT-PCR. Figure 6 showed that CFS
significantly down-regulated the expression of the hyphae-
specific genes ALS3 (0.140-fold), HWP1 (0.075-fold), and
ECE1 (0.045-fold), the differences were statistically significant
compared to MRS control (P < 0.01). The gene expression level
of SAP5 (1.283-fold) had no statistical difference compared to
the control (P > 0.05). Strikingly, EAP1 gene, which involved in
adhesion and biofilm formation, was found to be significantly up-
regulated by CFS treatment (2.590-fold, P < 0.01). In addition,
the expression level of negative transcriptional regulator NRG1
was also found to be significantly up-regulated (1.911-fold,
P < 0.05), while two hyphae activator regulatory genes TEC1
(1.272-fold) and EFG1 (1.200-fold) involved in C. albicans
FIGURE 1 | Inhibition effects of CFS from different Lactobacillus strains on Candida albicans growth in YPD broth at 24 h after inoculation.
(A) L. crispatus, (B) L. gasseri, (C) L. jensenii. Each bar is the mean ± SD from three independent experiments. ∗∗P < 0.01 compared to control by Student’s t-test.
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FIGURE 2 | Inhibition of C. albicans growth by CFS and catalase-treated CFS. Growth inhibition rate (%) = (ODcontrol – ODCFS)/ODcontrol × 100. The statistical
comparison between the catalase untreated and treated groups for each of the CFS was performed by Student’s t-test. ∗P < 0.05, ∗∗P < 0.01.
FIGURE 3 | Inhibition of hyphal formation by CFS. (A) Effect of CFS on C. albicans hyphal formation on solid RPMI 1640 + 10% FBS medium. Plates were
incubated at 37◦C for 5 days. Images of colony edges were obtained using a stereomicroscope, original magnification: 6.6×. (B) Effect of CFS on C. albicans hyphal
formation in liquid RPMI 1640 + 10% FBS medium for 4 h at 37◦C. Images of cellular morphology were obtained using a light microscopy, original magnification:
400×.
morphogenesis were found to have no statistical difference
compared to the control (P > 0.05).
Comparing the different effects of CFS on C. albicans gene
expression, we found that all seven L. crispatus CFS significantly
down-regulated the expression of ALS3, HWP,1 and ECE1 genes
(Figure 6), and there were no inter-strain difference except for
gene HWP1 (by LSD test: B145 vs. B535, P = 0.026; B535 vs.
B135, P = 0.024) (Figures 7F–H). In contrast, the up- and
down-regulation phenomena seemed to exist for each of the other
five C. albicans genes affected by CFS. According to the results of
paired comparison, there were statistically significant inter-strain
differences for NRG1, TEC1, EFG1, and EAP1 (Figures 7A–D)
but not for SAP5 (Figure 7E). Collectively, the results suggested
that each L. crispatus strains might have slightly different ability
and mechanism to regulate C. albicans gene expression. Among
seven tested L. crispatus strains, L. crispatus B145 displayed
the strongest regulatory activities in terms of down-regulations
of ALS3, HWP1, and ECE1 expressions, and up-regulation
Frontiers in Microbiology | www.frontiersin.org 6 April 2017 | Volume 8 | Article 564
fmicb-08-00564 April 1, 2017 Time: 16:55 # 7
Wang et al. Vaginal Lactobacilli against Candida albicans
FIGURE 4 | Inhibition effects of CFS from different Lactobacillus strains on C. albicans hyphal formation. (A) L. crispatus, (B) L. gasseri, (C) L. jensenii.
Effect of the addition of CFS on the yeast-to-hyphae conversion induced by liquid RPMI 1640 + 10% FBS medium at 37◦C for 4 h in microtiter wells.
FIGURE 5 | Inhibition of growth and hyphal formation of C. albicans by CFS from L. crispatus, L. gasseri, and L. jensenii. (A) Growth inhibition rate
(%) = (ODcontrol – ODCFS)/ODcontrol × 100, (B) Hyphae inhibition rate (%) = (Hyphae%control – Hyphae%CFS)/Hyphae%control × 100. Comparisons among three
groups were performed by one-way ANOVA followed by LSD test. ∗P < 0.05, ∗∗P < 0.01.
of NRG1 expression. Interestingly, this was in line with the
finding that L. crispatus B145 had the strongest activity to
inhibit yeast-to-hyphae transition (92.3± 9.2% hyphal formation
inhibition).
Characterization of
Anti-Candida-Related Compounds in
CFS Derived from L. crispatus B145
In order to get some preliminary information about the
chemical nature of the anti-Candida-related compounds secreted
by L. crispatus, the strain B145 was used for further study.
This strain was shown to have strong inhibition activities on
C. albicans growth in the absence and presence of catalase. It
also strongly inhibited the hyphal formation and some of the
related gene expressions. The susceptibility to heat was evaluated
by subjecting the B145 CFS to a number of thermal treatments:
60◦C for 30 min; 100◦C for 30 min; and 121◦C for 15 min.
The susceptibility to proteolytic enzymes was investigated by
exposing CFS to proteinase-K and trypsin (1 mg/mL; KeyGen
Biotech, Nanjing, China) for 3 h at 37◦C (Sangmanee and
Hongpattarakere, 2014).
The B145 CFS had about 60% growth inhibition activity on
C. albicans after heat and protease treatments with no significant
FIGURE 6 | The expression levels (fold change) of virulence-related
genes in C. albicans treated with CFS. ∗P < 0.05 and ∗∗P < 0.01
compared to control by Student’s t-test.
difference compared to that of the untreated CFS (P > 0.05)
(Figure 8A). In addition, the anti-hyphal activities of CFS
were significantly reduced after exposing to heat or protease
treatments compared to that of the untreated CFS (P < 0.01)
(Figure 8B). However, the residual activity of protease-treated
CFS was significantly lower than those of heat treatments
(P < 0.05).
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FIGURE 7 | The expression levels (fold change) of virulence-related genes in C. albicans treated with seven different CFS from L. crispatus. (A) NRG1,
(B) TEC1, (C) EFG1, (D) EAP1, (E) SAP5, (F) ALS3, (G) HWP1, (H) ECE1. Error bar represents SD from three biological replicates. Comparisons among multiple
groups were performed by one-way ANOVA followed by LSD test. ∗P < 0.05, ∗∗P < 0.01.
FIGURE 8 | Inhibition of growth and hyphal formation of C. albicans by CFS from L. crispatus B145. CFS: untreated CFS from L. crispatus B145, CFS-1:
CFS was heated at 80◦C for 30 min; CFS-2: CFS was heated at 100◦C for 30 min; CFS-3: CFS was heated at 121◦C for 15 min; and CFS-4: CFS was treated with
proteolytic enzymes. (A) Growth inhibition rate (%) = (ODcontrol – ODCFS)/ODcontrol × 100, (B) Hyphae inhibition rate (%) = (Hyphae%control – Hyphae%CFS)/
Hyphae%control × 100. ∗∗P < 0.01 compared to CFS by Student’s t-test.
These primarily results suggested that the growth and the
hyphal inhibition activities of L. crispatus B145 CFS might
be attributed to the antimicrobial compounds with different
chemical nature in terms of heat stability and protease
susceptibility.
DISCUSSION
Vulvovaginal candidiasis, primarily caused by C. albicans,
is one of the most common urogenital diseases affecting
women of reproductive-age and associated to the disruption
of the healthy vaginal microbiota (Achkar and Fries, 2010).
Lactobacillus-dominated microbiota is thought to be a valuable
biomarker for vaginal health since the Lactobacillus species
can create a barrier against pathogen invasion (Petrova et al.,
2015). L. crispatus, L. gasseri, and L. jensenii were the most
frequently isolated species in the vagina of healthy women
(Pendharkar et al., 2013; Al et al., 2014; Madhivanan et al.,
2015), where C. albicans is often a minority co-habitant of
vaginal microbiota. In this study, we investigated how these three
Lactobacillus species affected C. albicans growth and yeast-to-
hyphae transition, which are implicated in its pathogenesis.
We studied the antimicrobial activities of Lactobacillus strains
against C. albicans using two assays, i.e., the agar overlay method
and the microplate-based liquid medium assay. The results were
similar in terms of having or not having inhibition activities
except for three strains of L. jensenii (A083, B021, and B161)
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(Table 2 and Figure 1). The same phenomenon was also found
by other researches. For example, Coman et al. (2014) evaluated
the growth inhibition activities of L. rhamnosus IMC 501 R©
and L. paracasei IMC 502 R© on different pathogens by several
antimicrobial assays, such as agar well diffusion method and
liquid co-culture assay. They found that the inhibition results
were different within the different methods, and suggested that
this might be due to the various antimicrobial mechanisms. In
this study, the liquid medium assay using Lactobacillus CFS
seemed to be more sensitive to assess the antimicrobial activities,
where 100% (18/18) of the tested Lactobacillus strains showed
anti-Candida activities rather than 83.3% (15/18) in agar overlay
assay. We speculated that the solid agar might block the diffusion
of antimicrobial compounds to reach the target C. albicans, which
might affect those compounds with hydrophobic nature more
significantly. This also suggests the necessity of using different
methods in assessing the antimicrobial activities and comparing
results from different studies in an objective way. Anyhow, our
data suggests that the tested Lactobacillus strains had moderate
to strong anti-Candida activities with inter-strain variations. Our
results are consistent with some previous studies showing that
several strains of lactobacilli were effective at inhibiting the
growth of C. albicans (Parolin et al., 2015; Hütt et al., 2016).
Lactobacilli are known for their production of various
antimicrobial compounds to prevent vaginal infection (Borges
et al., 2014). H2O2 is one of the antimicrobial compounds. We
found that Lactobacillus strains had different H2O2 production
abilities, ranging from no evidence of H2O2 production to strong
production (Table 2). However, all tested Lactobacillus strains
showed growth inhibition effects on C. albicans regardless of
H2O2 production, suggesting that they might produce some
antimicrobial compounds in addition to H2O2. Organic acid
production and consequent pH reduction by lactobacilli growth
have also been suggested as one of the mechanisms for growth
inhibition on Candida in previous studies (Jiang et al., 2015).
However, we found that the anti-Candida activities of the tested
CFS might not be largely attributed to low pH (Figure 1).
Each of CFS from the tested Lactobacillus strains showed
significantly higher antimicrobial activity than MRS-HCl liquid
(pH 4.0) (P < 0.01). It suggests that other antimicrobial
compounds might play roles in the growth inhibition effects
of CFS on C. albicans. The antimicrobial compounds, such
as bacteriocin-like substances and biosurfactants, have been
suggested to contribute to the antagonistic effects of probiotic
Lactobacillus strains against a variety of vaginal pathogens
(Madhu and Prapulla, 2014; Maldonado-Barragán et al., 2016).
In this study, for the first time, the effects of CFS from three
species of Lactobacillus (L. crispatus, L. gasseri, and L. jensenii)
on yeast-to-hyphae transition of C. albicans were compared. The
ability of yeast-to-hyphae transition is essential for C. albicans
virulence (Mayer et al., 2013). The hyphae form, which can
promote tissue penetration and escape from immune cell, is
more prevalent in the infection process than yeast form (Lu
et al., 2014). Blocking of virulence traits of pathogens, such
as yeast-to-hyphae transition in C. albicans, has been recently
considered as a new antifungal paradigm (Tsang et al., 2012).
In this study, L. crispatus showed good inhibition activity on
hyphal formation (Figures 4, 5). Longitudinal studies have also
shown that the presence of L. crispatus promoted stability of the
vaginal microbiota toward a healthy status (Verstraelen et al.,
2009; Santiago et al., 2012). Our findings of L. crispatus strains
with generally high inhibition activities on Candida growth and
yeast-to-hyphae transition is very attractive. As far as we know,
the clinical approved L. crispatus strains are very limited. Our
results hint that L. crispatus strains are highly worthwhile for
further investigation in developing the new antifungal strategies.
Our preliminary results revealed that the antimicrobial
compounds from L. crispatus B145 against Candida growth were
heat stable and protease resistance. But the same treatments
would greatly reduce the residual activity against yeast-to-
hyphae transition. This hints that the growth and yeast-to-
hyphae transition inhibition activities would be attributed to
different secretory antimicrobial compounds of L. crispatus B145.
Tendulkar et al. (2007) have reported to identify a heat stable
and protease resistance biosurfactant compound, which had anti-
fungi activity. The compound was characterized to be lipopeptide
in chemical nature. To further study whether L. crispatus B145
was able to inhibit different clinical relevant C. albicans strains,
we tested the growth and hyphae inhibition effect of its CFS
on five additional vaginal isolates of C. albicans. We found
that the growth inhibition rates were from 50.7 to 68.6%,
and the hyphae formation inhibition rates were from 77.9 to
91.7% (Supplementary Figure S1). These results confirmed our
findings in C. albicans ATCC 10231. Further studies to purify the
bioactive compounds from L. crispatus B145 and to distinguish
different compounds in growth and hyphal inhibition would be
interesting.
To elucidate the potential mechanisms involved in the
inhibition of hyphal formation of C. albicans by the L. crispatus,
we studied the expression levels of five hyphae-specific genes, i.e.,
ALS3, HWP1, ECE1, EAP1, and SAP5, in response to L. crispatus
CFS under hyphae-inducing conditions. These genes encode
proteins that are essential for hyphal formation and also play roles
in Candida pathogenesis. ALS3 encodes Als3, which is a member
of the agglutinin-like sequence gene family and contributes to
the invasion of cells and subsequently cell damage (Liu and
Filler, 2011). HWP1 encodes a cell wall mannose protein, which
functions as an adhesion, required for hyphal formation and yeast
adhesion to epithelial cells (Orsi et al., 2014a). ECE1 encodes
a membrane protein, which is essential for cell elongation and
biofilm formation (Fan et al., 2013). EAP1 gene encodes a
glycosylphosphatidylinositol-anchored, glucan-cross-linked cell
wall protein, in adhesion and biofilm formation (Li and Palecek,
2003). SAP5 encodes a member of the secreted aspartic proteases
family, which are important for the pathogenesis of candidiasis
(Sanglard et al., 1997). The results of qRT-PCR analysis revealed
that all seven L. crispatus CFS significantly down-regulate the
expression of hyphal genes ALS3, HWP1, and ECE1, associated
with the inhibition of hyphal formation. Moreover, C. albicans
hyphal maintenance requires specific transcriptional regulation
mechanisms (Fan et al., 2013). We measured the expression of
positive regulator genes of EFG1 and TEC1, and the negative
regulator gene of NRG1 (Braun et al., 2001; Argimón et al.,
2007; Daniels et al., 2015). Expression of the negative hyphal
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regulator gene NRG1 was found to be significantly up-regulated
in C. albicans in the presence of L. crispatus CFS, implying
that L. crispatus might repress the expression of hyphae-
specific genes in a NRG1-dependent manner. To the best
of our knowledge, this is the first study demonstrating the
role of L. crispatus in inhibition of C. albicans virulence-
related gene expressions. Interestingly, L. crispatus B145 was
shown to strongly up-regulate NRG1 expression (3.398-fold) and
down-regulate ALS3 (0.057-fold), HWP1 (0.033-fold), and ECE1
(0.003-fold) gene expressions. If the antibodies are available,
experiments such as Western blot would further confirm this
finding.
CONCLUSION
The present study demonstrated the in vitro inhibitory effects
of vaginal L. crispatus, L. gasseri, and L. jensenii on C. albicans
growth and hyphal formation. L. crispatus had a generally
better ability to inhibit C. albicans and might down-regulate
the expression of hyphae-specific genes ALS3, HWP1, and ECE1
in a NRG1-dependent manner. The effects might be due to
their productions of some secretory antimicrobial compounds
in addition to H2O2 and organic acids. The growth and
hyphal inhibition compounds from L. crispatus B145 seemed
to be different in chemical nature. Further investigations on
L. crispatus B145 and other clinical isolates would facilitate the
development of probiotic agents with great potentials against
C. albicans.
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